CAPTRUST FINANCIAL ADVISORS - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 299 filers reported holding GW PHARMACEUTICALS PLC in Q1 2021. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$1,071,000
+87.9%
4,936
+0.0%
0.01%
+50.0%
Q4 2020$570,000
+20.3%
4,935
+0.5%
0.01%0.0%
Q3 2020$474,000
-23.5%
4,9100.0%0.01%
-20.0%
Q2 2020$620,000
+50.9%
4,910
+1.5%
0.01%
+11.1%
Q1 2020$411,000
-21.0%
4,839
-3.5%
0.01%
+12.5%
Q4 2019$520,0005,0140.01%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 450,000$55,224,0004.41%
Parkman Healthcare Partners LLC 119,778$14,699,0004.14%
Sio Capital Management, LLC 94,984$11,656,0003.40%
Tamarack Advisers, LP 90,000$11,045,0003.08%
Copernicus Capital Management, LLC 22,000$2,700,0002.96%
Integral Health Asset Management, LLC 75,000$9,204,0002.76%
ETF MANAGERS GROUP, LLC 480,145$58,923,0002.09%
AdvisorShares Investments LLC 29,758$3,652,0001.55%
Redwood Investments, LLC 130,444$16,008,0001.42%
CLOUGH CAPITAL PARTNERS L P 100,746$12,364,0001.21%
View complete list of GW PHARMACEUTICALS PLC shareholders